Streetbeat News

Products Services

EYEN

Formosa Pharmaceuticals has signed a non-binding terms agreement with Eyenovia to co-develop Clobetasol Propionate Ophthalmic Suspension for the relief of dry eye disease.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:01 pm

ZVSA

ZyVersa Therapeutics has announced the publication of data in a peer-reviewed journal demonstrating that extracellular ASC plays a crucial role in the aggregation and deposition of amyloid A fibrils, which are linked to chronic inflammatory conditions.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:56 am

REKR

Rekor Systems announced the initial adoption of its Rekor Command platform by Departments of Transportation in Oklahoma, Kansas, and Umatilla County, Oregon.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:41 am

NGNE

Neurogene's NGN-401 has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for the treatment of Rett Syndrome. This designation is expected to expedite the development and review process of NGN-401, potentially bringing a new treatment option to market faster.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:36 am

NWL

Newell Brands (NASDAQ:NWL), the maker of Sharpie pens, is shifting some of its production out of China to reduce tariff uncertainties. The company will relocate its writing business manufacturing to Tennessee and move kitchen appliance manufacturing to Vietnam, Thailand, Indonesia, and other locations. This strategic move aims to reduce Newell's dependence on China, automate U.S. manufacturing, and save on time and fluctuating freight costs.

Portfolio Pulse from Benzinga Neuro

August 07, 2024 | 11:34 am

GLCNF

TECK

Glencore (OTC:GLCNF) has decided not to spin off its coal business after acquiring Teck's (NYSE:TECK) coal assets. Shareholders preferred retaining the profitable unit, which aligns with ESG policies of major shareholders like BlackRock. Despite a 33% decline in first-half earnings, Glencore remains open to more acquisitions.

Portfolio Pulse from Stjepan Kalinic

August 07, 2024 | 11:34 am

ITCI

Intra-Cellular Therapies has projected its 2024 net product sales for CAPLYTA to be between $650 million and $680 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:32 am

SPNS

Sapiens announced that Continental General Insurance Company has selected it as a technology partner to accelerate operations, modernize its platform for future insurance products, and enhance its ability to scale in new markets.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:28 am

PLTR

WEN

Palantir Technologies and Wendy's Quality Supply Chain Co-op (QSCC) have announced a partnership to accelerate digital transformation, AI adoption, and operational decision-making across the co-op.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:27 am

CSIQ

Canadian Solar's subsidiary, E-storage, has been awarded a turnkey EPC contract for a 100 MW / 200 MWh energy storage project by Fotowatio Renewable Ventures (FRV) Australia for the Terang Energy Storage Project in Victoria.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:26 am